Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

Inclusion Criteria: * 19\~45 years healthy male * Body weight is over 55kg, BMI measurement 18.0kg/m\^2\~ 27.0kg/m\^2 * Signed informed consent form from to participate voluntarily and to comply with the trial requirements. * Researchers determined suitable volunteers through physical examination, laboratory tests Exclusion Criteria: * History of clinically significant liver, kidneys, nervous system, immune system, respiratory, endocrine disorders or tumor or blood disorders, cardiovascular diseases, mental disorders (mood disorders, obsessive-compulsive disorder, etc.) * Sitting SBP\>150mmHg or \<100mmHg, sitting DBP\>100mmHg or \<60mmHg, after 3 minutes break * An impossible one who participants in clinical trial by investigator's decision including laboratory test result or another reason. * Have a gastrointestinal disease history that can affect drug absorption (Crohn's disease ulcers, etc) or surgery (except simple appendectomy or hernia surgery) * History of drug abuse * Positive urine drug screening * Administrated investigational product in a previous clinical trial within 90 days of the first administration day in this study. * Donated blood within 60 days prior to the first administration day in this study.